# Methaemoglobinaemia {#sec-methb}

Methaemoglobin is an **altered form of haemoglobin** where the normal ferrous (Fe^2+^) iron of **haeme** become **oxidised** to the ferric (Fe^3+^) state, and **unable to bind oxygen**.

**Methaemoglobinaemia** is a **methaemoglobin level >1.5%**.

## Epidemiology and Risk Factors

## Pathophysiology

Methaemoglobinaemia occurs due to oxidation of the iron in haeme, and:

* Occurs normally\
Usually 0.5-3% of total haemoglobin per day.

### Aetiology

* Congenital
	* Cytochrome B5 reductase deficiency
* Acquired
	* Drugs
		* Nitrites
			* NO
			* SNP
			* Amyl nitrite
		* Metoclopramide		
		* Prilocaine
		* Benzocaine\
		Common adulterant in street cocaine.
		* Chloroquine
		* Dapsone

## Assessment

Features relate to impaired oxygen transport:

* Cyanosis\
This is paradoxical, as the SpO~2~ will generally be ~85% - too high to cause cyanosis.
* ↓ DO~2~
	* Angina
	* Dyspnoea
	* Confusion → obtundation
* SpO~2~ 85-90%

:::column-margin
: Symptoms by Methaemoglobin Level

+--------+------------------------+
| Level  | Features               |
+========+========================+
| <2%    | \-                     |
+--------+------------------------+
| 3-15%  | * Asymptomatic         |
|        | * Cyanosis *may* occur |
+--------+------------------------+
| 20-30% | * Fatigue              |
|        | * Dyspnoea             |
|        | * ↑ HR                 |
|        | * Nausea/vomiting      |
|        | * Anxiety, confusion   |
+--------+------------------------+
| \>40%  | * Arrhythmia           |
|        | * Shock                |
|        | * Seizure              |
|        | * Coma                 |
+--------+------------------------+
:::

### History

### Exam

### Investigations

**Bedside**:

:::column-margin
![Methaemoglobinaemia vs. Normal Blood](/resources/methb.png)
:::

* Brown blood test\
Brown discolouration of blood will remain unchanged as it clots. Normal blood will redden as it uptakes oxygen from the atmosphere.
* Pulse oximetry\
Typically reads 82-86%, independently of the true PaO~2~.
* ABG
	* Normal PO~2~
	* ↑ MetHb

**Laboratory**:

* Blood
	* MetHb levels

**Imaging**:

**Other**:

### Diagnostic Approach and DDx


## Management

:::priority
* Supplemental **oxygen**
* **Reduction** of methaemoglobin
:::

**Resuscitation**:

* B
	* Supplemental oxygen

**Specific therapy**:

:::column-margin
If methylene blue fails, consider:

* Ongoing exposure
* Sulfhaemoglobinaemia
	* Sulfonamides
	* Dapsone
* **G6PD deficiency**\
See @sec-G6PD.
* Haemoglobinopathy
* Excessive methylene blue 
:::

* Pharmacological
	* Reduction agents
		* **Methylene blue** 1-2mg/kg over 5 minutes
			* Artificial electron receptor, reduces MetHb by an NADPH dependent pathway\
			This requires G6PD, and will produce haemolysis in patients with G6PD deficiency.
			* Indicated for:
				* Symptomatic methaemoglobinaemia
				* Asymptomatic and:
					* MetHb >10% and vulnerable to ischaemia
					* MetHb >20%
			* Can repeat in 30-60 minutes
			* May induce methaemoglobinaemia in high doses
			* Contraindicated in:
				* G6PD
				* Serotonin syndrome
		* **Ascorbic acid** 1.5-3g IV Q6H
		* NAC
* Procedural
	* Exchange transfusion
	* Hyperbaric oxygen
* Physical

**Supportive care**:

**Disposition**:

**Preventative**:


### Marginal and Ineffective Therapies

## Anaesthetic Considerations

## Complications

## Prognosis

## Key Studies


---

## References

1. Paul A, Chacko ST. [Congenital methaemoglobinaemia diagnosed in an adolescent boy](https://casereports.bmj.com/content/12/3/e228470). BMJ Case Rep. 2019 Mar;12(3):e228470. 